Literature DB >> 26578246

Risk factors associated with Chagas disease in pregnant women in Santander, a highly endemic Colombian area.

Yeny Z Castellanos-Domínguez1, Zulma M Cucunubá2,3, Luis C Orozco1, Carlos A Valencia-Hernández2,3, Cielo M León2, Astrid C Florez2, Lyda Muñoz2, Paula Pavía4, Marleny Montilla2, Luz Marina Uribe5, Carlos García5, William Ardila5, Rubén Santiago Nicholls2, Concepción J Puerta4.   

Abstract

OBJECTIVE: To determine the prevalence and risk factors associated with Chagas disease in pregnant women in an endemic area of Santander, Colombia.
METHODS: Cross-sectional study included 23 municipalities of Santander, Colombia. Serological IFAT and ELISA tests were undertaken to detect IgG anti- Trypanosoma cruzi. A questionnaire was conducted for assessing the risk factors of each participant. Newborns were evaluated at birth and followed up to 1 year of age to determine congenital infection.
RESULTS: An overall prevalence of 3.2% (95% CI 2.4-4.2) among 1518 pregnant women was detected. Prevalences by provinces were as follows: Guanentina: 6.0% (95% CI 4.1-8.5), García Rovira: 2.9% (95% CI: 1.5-4.8) and Comunera: 0.4% (0.4-2.3). The main risk factors identified were age >32 years old (OR: 2.1; 95% CI: 1.1-3.9); currently having a thatched roof (OR: 11.8; CI95% 2.2-63.2) and a thatched roof during childhood (OR: 3.0; 95% CI: 1.4-6.6); having below primary school education level (OR: 4.6; 95% CI: 2.2-9.5); and a history of a close contact with the vector (triatomine bugs) at least once during their lifetime (OR: 6.9; 95% CI: 3.7-12.9). No congenital cases were detected by parasitological or serological techniques.
CONCLUSIONS: Prevalence of Chagas disease in pregnant women is a potential source of infection in this Colombian endemic area. The main risk factors associated with seropositivity were related to conditions favouring the contact with the vector. The results show that it is necessary to continue an active surveillance in order to offer diagnosis and treatment to mothers and their newborns in addition to screening to pregnant women from endemic areas.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Trypanosoma cruzizzm321990; Chagas congénito; Chagas disease; Trypanosoma cruzi; congenital Chagas disease; diagnostic sérologique; diagnóstico serológico; embarazo; enfermedad de Chagas; facteurs de risque; factores de riesgo; grossesse; maladie de Chagas; maladie de Chagas congénitale; pregnancy; risk factors; serological diagnosis

Year:  2015        PMID: 26578246      PMCID: PMC4737279          DOI: 10.1111/tmi.12634

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


Introduction

Chagas disease is an important public health problem in Latin American countries. In Colombia, vectorborne is the main transmission route and Rhodnius prolixus is the predominant species of vector 1. Risk factors relate to environmental, cultural and social vulnerabilities such as living conditions, housing and poverty in rural areas; and these have allowed national programmes to target the most endemic areas for vector control 2. However, additional strategies are needed to control other routes of parasite transmission (congenital, oral, transfusion) 3. Congenital transmission has gained special importance in some zones where vector transmission has been interrupted. Hence, in some endemic countries like Argentina, the rate of congenital transmission can account for up to 10 times the number of acute vectorborne cases 4. Congenital cases have been widely reported even in countries where the infection is non‐endemic due to international migration from endemic countries 5, 6. Congenital transmission occurs when the parasites cross the placental barrier during pregnancy 7, 8, 9. There are two effective trypanocidal drugs (benznidazole and nifurtimox) for reducing parasitemia, but they are explicitly contraindicated during pregnancy due to their potential teratogenic adverse effects 8, 10. However, there is recent evidence of the potential of trypanocidal drugs for preventing congenital transmission when women are treated before pregnancy 11. In South American countries, the prevalence of Trypanosoma cruzi seropositivity in pregnancy ranges from 0.3% to 49.5% 12, 13, 14, 15, 16 and the transmission probability from infected mother to child has been estimated at 4.7% (95% CI: 3.9–5.6) in a meta‐analysis 17. Although about 90% of congenital cases are asymptomatic at birth, some cases present varied symptoms such as low weight, hepatosplenomegaly, jaundice and anaemia 18. Both the prevalence of infection in pregnant women and the transmission pattern of congenital infection in Colombia are unknown 19. Only two previous studies have determined the prevalence in pregnant women in parts of the country: 3.3% in Boyacá 20 and 4% in Casanare 21. This study determines the prevalence of T. cruzi seropositivity in pregnant women and accordingly the frequency of congenital transmission in an endemic area previously unexplored in this regard.

Methods

Study design

A cross‐sectional study was performed between August 2010 and December 2013 in the Department of Santander (first administrative order), specifically in three provinces (intermediate administrative order): García Rovira, Guanentina and Comunera, and 23 municipalities (second administrative order) (Figure 1).
Figure 1

Map of the participant municipalities in the Guanentina, Comunera and García Rovira provinces, Santander, Colombia.

Map of the participant municipalities in the Guanentina, Comunera and García Rovira provinces, Santander, Colombia. Pregnant women were recruited from August 2011 until September 2011, and their newborns were followed up until the age of 12 months. The sample size was calculated according to an estimate of about 3000 pregnant women per year attending the health facilities in these 23 municipalities. Based on previous work, the expected prevalence was 3.9% 20, 21, therefore with a confidence level of 95%, and a precision of 1%, a required minimum sample size of 1440 pregnant women was estimated to successfully determine the overall prevalence in this area.

Inclusion of participants and follow‐up

The inclusion criteria for municipalities in these three provinces were being a Chagas endemic area for domiciliary transmission and having a primary care facility with a regular pregnancy care programme. The inclusion criteria for individual participants were as follows: (i) acceptance of pregnant women to participate in the diagnosis phase; (ii) acceptance of the mother to participate in the follow‐up of her newborn once she was identified as seropositive; and (iii) written informed consent. Several meetings at municipality level were conducted to inform health workers from the 23 hospitals about the study. The local teams who facilitated the inclusion and follow‐up were comprised of a physician, a nurse and laboratory technicians. They were trained for helping out with the inclusion procedures, filling‐in questionnaires, collecting samples, contacting patients and directing infected pregnant women towards attending a series of specific consultations with the researchers for the follow‐up phase of the study. For diagnosis of pregnant women and children, two techniques were used as follows: ELISA and IFAT to detect anti‐T. cruzi IgG. These tests were standardised and evaluated at the National Health Institute 22, 23, 24. Discordant results were then processed by the indirect haemagglutination (IHA) commercial test (Winner®, Rosario, Argentina). Microhaematocrit was processed according to the technique previously described by Freilij 25 and modified by Torrico 26; the IHA was also used for parasitological diagnosis of newborns. The children underwent serological tests and were considered as cases when the tests were reactive after 9 months of age. Once a pregnant woman was confirmed as positive by two serological tests, she was informed about the need to follow‐up her baby after birth. Clinical examination and samples for microhaematocrit and serology were taken at birth and up to 12 months of age. Aetiological (parasiticidal) treatment with nifurtimox (Lampit®) was offered to all confirmed cases.

Ethical aspects

Pregnant women were invited to participate voluntarily during the prenatal consultation at the local hospital, after being informed about the goal, objectives, procedures and benefits of the study. Written informed consent was obtained from all participants, following national and international regulations. The research protocol was approved by the Committee on Research Ethics of Colombia's National Health Institute.

Survey questionnaires and data quality control

The questionnaires contained information on socio‐demographic variables (residency, age, marital status, education and occupancy), housing characteristics (construction materials of the roof, walls and floor) for both current and childhood homes, recognition and contact with the vector (past and current), history of transfusions, and information on relatives with previous diagnosis of Chagas disease. During the interview, a box with desiccated insects of the four principal triatomine species (R. prolixus, Triatoma maculata, Triatoma dimidiata, Panstrongylus geniculatus) was shown to the pregnant women, who were asked to identify their interaction with the vectors as either ‘simple recognition’ or ‘close contact’. Simple recognition was defined as having seen the vector at least once in their lifetime in their houses or in another place (trees, palms, other houses). This was intended as a proxy indicator of a potential exposure but not remembering any particular contact. Close contact was defined as remembering having been bitten by vectors or seeing them full of blood emerging from the bed where the women slept. To control for potential information bias, the local teams participating in the study received specific training sessions on the questionnaires and procedures and as a quality control they were regularly reassessed and if necessary received additional training. For data quality control, the fieldwork coordinator revised and evaluated the quality of the questionnaires. In the case of missing data, patients were re‐contacted to obtain the specific information. The questionnaires were entered in an MS Excel® database, a random sample of 2% of the questionnaires was reviewed in detail, and patients were called to corroborate the validity and reliability of the information provided.

Data analysis

Frequencies were calculated and displayed as percentages with their 95% confidence intervals (95% CI). Potential risk factors were evaluated through bivariate analysis as odds ratio (OR) and then through stratified and multivariate analysis by logistic regression. For the latter, a stepwise backward removal method, dropping variables with P values <0.2, was used for controlling confounding variables and choosing the final model, for which only variables with P value <0.05 were included. Akaike information criteria (AIC) were also used to choose the best model fit. All the data analysis was performed using Stata 10.0 (Stata Corp. 2007, release 10; StataCorp LP, College Station, TX, USA).

Results

Univariate analysis

A total of 23 health facilities from 23 municipalities in the three endemic provinces participated in the study. All municipalities and all the mothers invited to participate in the study accepted. A total of 1518 pregnant women aged 13–46 years (average: 24.5 years; standard deviation: 6.9 years) were included. The overall prevalence was 3.2%. The Guanentina province had the largest number of cases (30 infected pregnant women). At municipality level, Mogotes presented the highest prevalence (18.3%). The frequency of infected pregnant women by municipalities and provinces is presented in Table 1.
Table 1

Prevalence of seropositivity in pregnant women in the municipalities of three provinces, Santander, Colombia

Province/Municipalitya NegativePositiveTotalProportion (%) of sero[+]95% CI
Guanentina Province
Curiti291303.30.1–17.2
Charalá140140.00.0–23.1
Coromoro362385.30.6–17.7
Mogotes942111518.311.6–26.5
Onzaga250250.00.0–13.7
San Gil22242261.80.5–4.5
San Joaquín472494.10.5–14.0
Subtotal467304976.04.1–8.5
Comunera Province
Gámbita130130.00.0–24.7
Guacamayo230230.00.0–14.8
Socorro32453291.50.5–3.5
Suaita400400.00.0–8.8
Oiba13811390.70.0–3.9
Hato4040.00.0–60.2
Palmas del Socorro3030.00.0–70.8
Simacota150150.00.0–21.8
Subtotal56065661.10.4–2.3
García Rovira Province
Capitanejo914954.21.2–10.4
Concepción250250.00.0–13.7
Enciso62825.03.2–65.1
Macaravita352375.40.7–18.2
Molagavita512533.80.5–13.0
Málaga18611870.50.0–2.9
San Jose de Miranda401412.40.1–12.9
San Miguel81911.10.3–48.2
Subtotal442134552.91.5–4.8
Total14694915183.22.4–4.2

Department is the first administrative order. Municipality is second administrative order. Province is an intermediate level between department and municipality.

Prevalence of seropositivity in pregnant women in the municipalities of three provinces, Santander, Colombia Department is the first administrative order. Municipality is second administrative order. Province is an intermediate level between department and municipality. 52.2% were from rural areas and 47.8% from urban areas; 67.7% belonged to the lower socio‐economic strata (1 or 2) and 80.0% were affiliated to subsidised health care. 55.5% had finished high school and 33.2% had no education at all. 77.9% were either married or had a partner at the time of the survey. 78.5% were housewives and 13.8% were high school students; 43.2% recognised the Chagas disease vector (Triatominae), and only 11.1% reported any contact with it sometime in the past (Table 2).
Table 2

Bivariate analysis for potential risk factors associated with seropositive pregnant women in Santander, Colombia

Variable n sero[+]%OR95% CIP
Socio‐demographic factors
Residence area
Urban area725131.7910.003
Rural area793364.542.61.3–5.4
Age
13–1938241.051
20–24447132.912.80.9–8.4<0.001
25–2930151.661.60.4–5.9
30–42388276.966.62.3–18.8
Socio‐economic strata
High (3,4,5)49191.8310.034
Low (0,1,2)1027403.892.21.0–4.5
Healthcare insurance
Contributive15131.9910.211
Non‐insured15221.321.50.3–9.1
Subsidised1215443.622.80.7–11.7
Education level
University17221.161<0.001
High School84291.070.90.2–4.3
Primary School493367.306.71.6–28.1
None11218.1818.92.4–149.9
Marital status
Married1183433.6310.124
Single32151.560.40.2–1.1
Widow‐separated1417.1420.3–15.9
Occupation
Housewife1192463.8610.068
Student20920.960.20.6–1.0
Worker in urban area9611.040.30.0–1.9
Worker in rural area (agriculture)2100.00
Factors related with triatomine vectors exposure
Recognition of the vector
No809101.241 <0.001
Yes656395.955.12.5–10.2
Close contact with vectors at least once in lifetime
No1186211.771 <0.001
Yes1692514.799.65.3–17.7
No response16331.8410.3–3.5
Close contact with vectors during the last year
No1336443.2910.283
Yes2627.692.40.6–10.7
Close contact with animals
No462163.4610.732
Yes1056333.130.90.5–1.7
Housing conditions
Current floor
Cement1241322.581 <0.001
Wood3625.562.20.5–9.7
Dirt190157.893.21.7–6.1
Other5100.00
Current roof
Clay tiles601203.331
Fibrocement tiles552183.2610.5–1.9 <0.001
Thatched/palm leaves12325.009.72.4–38.5
Other35382.270.70.3–1.5
Current wall
Brick/cement1109282.521 0.02
Wood19210.534.51.0–20.6
Adobe371195.122.11.2–3.8
Other1900.00
Floor of housing during childhood
Cement796162.011 0.003
Wood6800.00
Dirt639335.162.71.5–4.9
Other1500.00
Roof during childhood
Clay tiles753222.921 <0.0001
Fibrocement tiles40881.960.70.3–1.5
Thatched/palm leaves921213.0452.4–10.5
Other26572.640.90.4–2.1
Walls of housing during childhood
Brick/cement737121.631 0.004
Wood7022.861.80.4–8.1
Adobe676345.033.21.6–6.2
Other3512.861.80.2–14.1
Other factors
Relatives diagnosed with Chagas disease
No1320392.951 0.022
Yes10198.913.21.5–6.8
No response9711.030.30.1–2.5
Previous transfusions
No1467483.2710.578
Yes2900.00

Bold numbers mean p values statistically signifciant at <0.05.

Bivariate analysis for potential risk factors associated with seropositive pregnant women in Santander, Colombia Bold numbers mean p values statistically signifciant at <0.05.

Bivariate analysis and multivariate analysis

In the bivariate analysis, low socio‐economic status, low level of education, age above 30 years, knowledge of the vector, and contact with the vector at least once during lifetime were significantly associated with seropositivity. Having lived in childhood or living currently in rural area and in houses with dirt floor, thatched roof and adobe walls were also statistically significant (Table 2). To identify potential interactions, a stratified analysis by age groups was conducted with the variables identified as statistically significant in the bivariate analysis, evidencing no modification of the effect with age. In the logistic regression model, the final variables associated with seropositivity were as follows: age >32 years, less than primary schooleducation, previous contact with the vector at least once in the lifetime, and having lived in a house with thatched roof in childhood (Table 3).
Table 3

Logistic regression model for seropositive pregnant women of Santander

VariableOR95% CI P
Current thatch roof11.82.2–63.20.004
Close contact with vector at least once on life6.93.7–12.9<0.001
Low education level4.62.2–9.5<0.001
Thatch roof during childhood3.01.4–6.60.005
Age >32 years2.11.1–3.90.024
Logistic regression model for seropositive pregnant women of Santander

Follow‐up of newborns and search for congenital infection

The 49 infected women had a successful delivery with no abortions or deaths at birth. After birth, one child died due to respiratory infection at 3 months. One participating mother from the Socorro municipality initially refused to continue in the study after being diagnosed as seropositive, so it was not possible to take samples from the newborn, but it was possible to follow‐up the child after 1 year. Follow‐up of 48 newborns continued until they reached 12 months of age; no congenital cases were identified through parasitological or serological tests. The transmission rate from mother to children was then estimated at 0% (95% CI: 0.0–7.3%) for this population.

Discussion

The overall prevalence found in this endemic area was 3.2% (95% CI: 2.39–4.24), similar to the prevalence reported for two other Colombian endemic areas in recent studies: 4% in Casanare in 2011 21 and 3.34% Boyacá in 2007 20. Santander has been one of the high endemic departments in Colombia 1. In previous studies, the prevalence of Chagas disease in general population had reached 52.5% 27 and 6.9% in children 3 in this department. The only previous study in pregnant women in this department was conducted in the capital city, Bucaramanga, in 1993 when a prevalence of 6.9% in women at delivery in a specialised level hospital was found 28. Thus, the prevalence almost 15 years ago was higher than in the current study, which is the observable trend for other endemic areas 21. This difference over time could be explained by the scaling‐up of vector control measures in this area since the beginning of the 21st century 1. A similar trend was found in Paraguay in the prevalence in pregnant women in two endemic municipalities in 1995 (15% and 12%) and 2009, when the prevalence dropped to 6% in both sites 29. One of the most striking results was the high prevalence found in Mogotes, which is one of the most endemic municipalities in Colombia. As part of the Andean countries initiative for the control of Chagas disease in the 1990s, an integrated domiciliary vector infestation control programme was created to guide the vigilance and control actions of high‐risk municipalities. This initiative involved the participation of 30 municipalities in Santander but Mogotes was not part of such strategy and no systematic vector control took place there 1. This result supports the hypothesis that vector control is an important factor in explaining temporal changes to prevalence and accounts for the substantial difference in prevalence between Mogotes and other municipalities. In our study, age was an important risk factor for T. cruzi seropositivity. Specifically, being older than 32 resulted in twice the risk of having positive serology. This confirms similar findings in Argentina 30, Bolivia 31, another endemic area of Colombia 21 and recently in El Salvador 32. This recurrent finding reflects the typical seroprevalence profile due to accumulated exposure with age in areas of domiciliary transmission. A history of living in poor housing conditions (specifically in houses with thatched roofs) was a risk factor for seropositivity (OR 3.0; 95% CI: 1.4–6.6), which increases significantly if women continue living in such conditions (OR 11.8; 95% CI: 2.2–63.2). Housing conditions are the most important risk factors associated with triatomine infestation in Colombia and Argentina 2, 33. Even though some variables such as socio‐economic conditions and living in rural areas were statistically significant in the bivariate analysis, they did were not relevant in the final model. This may be due to correlation between those variables and the ones that were finally presented in the model such as thatch roof and level of education. Recollection of at least one ‘close contact’ (a bite or seeing a vector in bed) also was a clear risk factor, although ‘simple recognition’ did not represent a risk. In Colombia, and particularly the department of Santander, several oral outbreaks have been reported in the last years 34, 35, 36, 37. Interestingly, for the majority of foodborne outbreaks for which a triatomine infection source has been identified, these have usually been species that are not usually associated with vectorial transmission, and mostly P. geniculatus 38. Given the epidemiological history of vectorial transmission in the areas involved in this study, and also the association with housing conditions for intradomiciliary transmission, oral transmission seems less likely to be a driver of prevalence of infection in this population. With respect to performance of the diagnostic tests, ELISA and IFI have been evaluated and presented in detailed in previous studies 24. The reproducibility between these two tests was almost perfect with a kappa coefficient of 0.98 so the HAI test was only necessary to confirm the seropositive status in a few cases. Because the local doctors and health personal participating in this study were trained for both diagnosis and treatment, the study was a great opportunity to generate awareness among healthcare workers and the community about congenital Chagas disease. Recent studies have highlighted the importance of increasing awareness at local level as a crucial tool to improve diagnosis and disease control 39. For all pregnant women diagnosed in this study, aetiological treatment was offered and given after delivery through the local hospitals. The decision of treating all mothers (after pregnancy) despite the absence of congenital transmission in this particular study was considered appropriate given that in other endemic departments of the country this type of transmission has been reported 20 and we cannot dismiss the possibility of transmission in future pregnancies. The trypanocidal treatment of women with chronic Chagas infection before pregnancy prevents congenital transmission of T. cruzi to their children 11. This group of young and mostly healthy women could potentially benefit from aetiological treatment in terms of reducing the possibility of developing heart complications 40. A potential limitation of this study is that we only included pregnant women who attended antenatal control clinics in hospitals. Despite the fact that the coverage of antenatal care in Colombia has been increasing in the last decades and for 2010 it was estimated at 97% 41, this still could represent a potential bias in omitting the poorest women who only seek hospital care for delivery or who do not seek care at any time and who are the patients at the highest risk of T. cruzi seropositivity. Another potential limitation of this study, considering a recent meta‐analysis has estimated the transmission rate of congenital Chagas disease at 4.7% (95% CI: 3.9–5.6) 17, is that the sample size of newborns (49 children) was not enough to find congenital cases. This study updates epidemiological data on Chagas disease prevalence in pregnant women in a Colombian endemic area. The identified risk factors will allow the local health providers to target more precisely the necessary interventions for this specific population. The fact that no congenital cases were found in this series of pregnant women does not mean that this transmission route is not present in this department. There is still a need to guarantee the proper diagnosis at birth and the clinical and laboratory follow‐up to all children born from infected women, as recently recommended 42. Providing care and aetiological treatment to infected women of childbearing age before they become pregnant is also imperative in order to reduce the probability of the disease progression and prevent congenital transmission.
  32 in total

1.  Congenital infection with Trypanosoma cruzi: from mechanisms of transmission to strategies for diagnosis and control.

Authors: 
Journal:  Rev Soc Bras Med Trop       Date:  2003 Nov-Dec       Impact factor: 1.581

2.  Detectable Trypanosoma cruzi parasitemia during pregnancy and delivery as a risk factor for congenital Chagas disease.

Authors:  Laurent Brutus; Helen Castillo; Claudia Bernal; Nadin Alejandra Salas; Dominique Schneider; José-Antonio Santalla; Jean-Philippe Chippaux
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

3.  Congenital Trypanosoma cruzi infection. Efficacy of its monitoring in an urban reference health center in a non-endemic area of Argentina.

Authors:  Ana María De Rissio; Adelina Rosa Riarte; Miriam Martín García; Mónica Inés Esteva; Marta Quaglino; Andrés Mariano Ruiz
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

4.  Risk factors for Chagas disease among pregnant women in El Salvador.

Authors:  Emi Sasagawa; Hirotsugu Aiga; Edith Y Corado; Blanca L Cuyuch; Marta A Hernández; Ana V Guevara; José E Romero; Hector M Ramos; Rafael A Cedillos; Chizuru Misago; Kiyoshi Kita
Journal:  Trop Med Int Health       Date:  2014-12-12       Impact factor: 2.622

5.  Comparison of four serological tests for the diagnosis of Chagas disease in a Colombian endemic area.

Authors:  R Gutierrez; V M Angulo; Z Tarazona; C Britto; O Fernandes
Journal:  Parasitology       Date:  2004-10       Impact factor: 3.234

Review 6.  Infection and invasion mechanisms of Trypanosoma cruzi in the congenital transmission of Chagas' disease: a proposal.

Authors:  Ulrike Kemmerling; Cleo Bosco; Norbel Galanti
Journal:  Biol Res       Date:  2010-11-30       Impact factor: 5.612

7.  Congenital Chagas disease: diagnostic and clinical aspects in an area without vectorial transmission, Bermejo, Bolivia.

Authors:  L Brutus; D Schneider; J Postigo; M Romero; J Santalla; J P Chippaux
Journal:  Acta Trop       Date:  2008-03-27       Impact factor: 3.112

8.  House-level risk factors for triatomine infestation in Colombia.

Authors:  D H Campbell-Lendrum; V M Angulo; L Esteban; Z Tarazona; G J Parra; M Restrepo; B N Restrepo; F Guhl; N Pinto; G Aguilera; P Wilkinson; C R Davies
Journal:  Int J Epidemiol       Date:  2007-08-14       Impact factor: 7.196

9.  Towards a paradigm shift in the treatment of chronic Chagas disease.

Authors:  R Viotti; B Alarcón de Noya; T Araujo-Jorge; M J Grijalva; F Guhl; M C López; J M Ramsey; I Ribeiro; A G Schijman; S Sosa-Estani; F Torrico; J Gascon
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

10.  Controlling congenital and paediatric chagas disease through a community health approach with active surveillance and promotion of paediatric awareness.

Authors:  Antoni Soriano-Arandes; Luca Basile; Hakima Ouaarab; Isabel Clavería; Jordi Gómez i Prat; Juan Cabezos; Pilar Ciruela; Pedro Albajar-Viñas; Mireia Jané
Journal:  BMC Public Health       Date:  2014-11-21       Impact factor: 3.295

View more
  6 in total

1.  Molecular Diagnosis of Chagas Disease in Colombia: Parasitic Loads and Discrete Typing Units in Patients from Acute and Chronic Phases.

Authors:  Carolina Hernández; Zulma Cucunubá; Carolina Flórez; Mario Olivera; Carlos Valencia; Pilar Zambrano; Cielo León; Juan David Ramírez
Journal:  PLoS Negl Trop Dis       Date:  2016-09-20

2.  Modelling historical changes in the force-of-infection of Chagas disease to inform control and elimination programmes: application in Colombia.

Authors:  Zulma M Cucunubá; Pierre Nouvellet; Lesong Conteh; Mauricio Javier Vera; Victor Manuel Angulo; Juan Carlos Dib; Gabriel Jaime Parra-Henao; María Gloria Basáñez
Journal:  BMJ Glob Health       Date:  2017-09-07

3.  Prevalence of Chagas disease in Colombia: A systematic review and meta-analysis.

Authors:  Mario J Olivera; Johana A Fory; Julián F Porras; Giancarlo Buitrago
Journal:  PLoS One       Date:  2019-01-07       Impact factor: 3.240

4.  Epidemiology of congenital Chagas disease 6 years after implementation of a public health surveillance system, Catalonia, 2010 to 2015.

Authors:  Luca Basile; Pilar Ciruela; Ana Requena-Méndez; Mª José Vidal; Eva Dopico; Andrea Martín-Nalda; Elena Sulleiro; Joaquim Gascon; Mireia Jané
Journal:  Euro Surveill       Date:  2019-06

5.  Risk Factors for Maternal Chagas Disease and Vertical Transmission in a Bolivian Hospital.

Authors:  Melissa D Klein; Freddy Tinajeros; María Del Carmen Menduiña; Edith Málaga; Beth J Condori; Manuela Verástegui; Federico Urquizu; Robert H Gilman; Natalie M Bowman
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079

6.  Trypanosoma cruzi infection in puerperal women and their neonates at Barcelona, Anzoategui State, Venezuela

Authors:  Norielis Del Carmen Zabala; Mariolga Berrizbeitia; Alicia Jorquera; Jessicca Rodríguez; Leomery Romero
Journal:  Biomedica       Date:  2019-12-01       Impact factor: 0.935

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.